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To date, the genes associated with susceptibility to Atopic Eczema (AE) are mainly implicated in immunity, inflammation, and
maintenance of skin barrier. Little is known about the possible relationship between genesmodulating Extra-CellularMatrix (ECM)
and AE etiopathogenesis. In this regard, the primary objective of the present study has been the investigation of susceptibility
biomarkers localized within genes encoding collagen proteins. Several studies have shown that polymorphisms within the genes
encoding such proteins may generate abnormal connective tissues, making them more susceptible to mechanical stress, loss of
epidermal integrity, and aging.We therefore decided to investigate three polymorphisms located inCOL6A5, COL8A1, andCOL10A1
as potential susceptibility biomarkers for AE in a cohort of 1470 subjects of Mediterranean origin. The genes of interest have
been selected considering that the ECM and immune/inflammatory response are strongly dysregulated in AE and other complex
disorders. The study confirmed that the susceptibility to AE depends on a complex interaction between latitude, geographical
localization, and the differential distribution of genetic variants among populations exposed to similar environmental factors.
1. Introduction
Atopic Eczema (AE, OMIM #603165) is one of the most
common chronic dermatological diseases caused by the
disruption of the skin barrier and the dysregulation of
immune and inflammatory responses [1]. Clinical features
of the disease include variable age of onset, red blotches,
and itchy rashes that quickly develop into painful papule,
xerosis, erythematous lesions with increased transepidermal
water loss, and disruption of the epidermal barrier function
[2]. AE affects approximately 1-3% of the adult popula-
tion and 15-20% of children, depending on population and
geographical localization. In particular, higher prevalence
(≥15%) of disease has been observed among populations
living in Northern Europe (England, Denmark, Norway,
Ireland) and Asia (Japan, Korea, Taiwan) while Southern
Europe and Mediterranean areas (Turkey, Malta, Croatia,
Spain, Italy, Greece, Egypt) reported lower prevalence (≤5%)
rates [3]. The variable prevalence across the world might
reflect the influence of different UV exposure with respect
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to latitude and geographic localization. This variability may
in turn be responsible for a different genetic adaptation to
local environmentwhich ultimately determines a population-
specific susceptibility to AE. Genetic adaptation is meant as
the positive/negative presence for variants localized within
genes involved in the regulation of skin permeability and
response to UV radiations. An excellent example of this
condition is represented by the mutational spectrum of
the FLG (1q21) gene associated with AE. Interestingly, the
frequency of FLG mutations showed a heterogeneous dis-
tribution between Northern European and Mediterranean
subjects (0% in Mediterranean areas vs. 10% in Northern
Europe) [4, 5].
However, although FLG mutations are one of the most
predisposing factors to the disease, other genetic variations
can also be critical for the onset and severity of AE. The
presence of several susceptibility loci can be easily explicated
by the multifactorial etiology of the disease that depends
on the complex interaction between environmental factors
(toxin, skin irritants, climate pollutants, and microorgan-
isms) and multiple genes variations. To date, more than 30
loci have been associated with a higher risk of AE [6–8]. All
of the genes which have been identified so far are essentially
implicated in the immune and inflammatory responses and
in the maintenance of skin barrier. Little is known about
the possible relationship between genes modulating Extra-
Cellular Matrix (ECM) and AE etiopathogenesis. In this
regard, the primary objective of the present study has been
the investigation of susceptibility biomarkers localized within
genes encoding collagen proteins. Collagen is a fibrous
protein primarily involved in the formation andmaintenance
of structural components such as cartilage, bone, epidermis,
cornea, and blood vessels. To date, at least 28 subtypes of
collagen are known to be differentially expressed in body
tissues. Several studies have shown that polymorphisms
within the genes encoding such proteins may generate abnor-
mal connective tissues which may be more susceptible to
mechanical stress, loss of epidermal integrity, and aging [9–
12].We therefore decided to investigate three polymorphisms
located in COL6A5 (3q22.1), COL8A1 (3q12.1), and COL10A1
(6q22.1) as potential susceptibility biomarkers for AE in a
large cohort of Mediterranean origin. The genes of interest
have been selected considering that they are involved in the
organization of ECM and immune/inflammatory responses,
both of which are known to be strongly dysregulated in AE
and other complex disorders.
2. Material and Methods
2.1. Study Cohorts. The study was performed on 428 patients
affected by Atopic Eczema (AE) from Italy, Egypt, and Greece
(collectively referred to as Mediterranean populations). In
particular, 285 Italian individuals were recruited from the
Immunoallergology Unit of San Pietro Fatebenefratelli Hos-
pital of Rome and IDI (IstitutoDermopatico dell’Immacolata,
Rome); 87 Egyptian individuals were enrolled from the
University of Alexandria and 56 Greek individuals from
the Aristotle University Medical School, Thessaloniki. The
clinical diagnosis fulfilled the diagnostic criteria of the “UK
Working Party for Atopic Dermatitis” [13] and was assessed
either by expert dermatologists or by pediatric allergologists.
Concerning control subjects, 992 healthy individuals of
Mediterranean ancestry were enrolled from “Tor Vergata”
General Hospital of Rome. In addition, 50 Greek healthy
subjects from Aristotle University Medical School (Thessa-
loniki, Greece) were subsequently included in this study. The
diagnosis of AE was excluded for all control subjects at the
time of recruitment. The study was approved by the Ethics
Committee of each participating institute and was performed
according to the Declaration of Helsinki. All participants
provided signed informed consent.
2.2. DNA Extraction and Genotyping Analysis. Whole blood
samples were taken from patients and controls to extract
genomic DNA. DNA extraction was performed by the EZ1
Advanced XL automated extractor and the EZ1 DNA Blood
200𝜇l Kit (Qiagen). The genotyping analysis was performed
on a 7500 Fast Real Time PCR (Applied Biosystems) accord-
ing to manufacturer’s instructions. Specific predesigned Taq-
Man assays were utilized for COL6A5 (rs12488457, A/C),
COL8A1 (rs13081855, G/T), and COL10A1 (rs3812111, A/T)
genotyping. The results were interpreted using Sequence
Detection System 2.1 software (Applied Biosystems). Each
Real Time PCR run was performed using a negative control
and three positive control samples previously confirmed by
direct sequencing (BigDye Terminator v3.1, BigDyeXTermi-
nator) onABI3130xl (Applied Biosystems).Direct sequencing
of the samples was conducted following the manufacturer’s
indications.
2.3. Biostatistical Analysis. The genotyping results were sub-
jected to biostatistical analysis to evaluate the association
with AE. Allele and genotype frequencies of the analyzed
SNPs were calculated by direct counting. Hardy-Weinberg
Equilibrium (HWE) was tested at each locus, by compar-
ing the observed genotype frequencies with those expected
under HWE. Data were considered in HWE for p>0.05. The
association of the SNPs was measured by calculating the
p-value (p) through a contingency table and the 𝜒2 test.
The cut-off for statistical significance was set at a p<0.05.
The strength of association was determined by calculating
the Odd Ratio (OR) and a 95% confidence interval. All the
statistical analyses were performed using the SPSS program,
ver. 23 (IBM Corp).
2.4. Bioinformatic Analysis. Bioinformatic tools were em-
ployed to assess the “in silico” functional role of the analysed
SNPs. In particular,MutationTaster, Polyphen-2 andExPaSy-
Prosite [14–16] were used to predict the impact of the
associated SNPs on protein structure and function. Human
Splicing Finder was interrogated to assess whether the anal-
ysed SNPs could alter the splicing activity. All of these tools
normally utilize a set of algorithms and database to calculate
a reliable score and predict the effect size of the variants
taken into consideration. Gene enrichment tools available
from DAVID (Database for Annotation, Visualization and
Integrated Discovery) [17, 18] and KEGG (Kyoto Encyclopae-
dia of Genes and Genomes) [19] were used to investigate
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gene-gene interactions and their potential involvement in
disease-associated molecular pathways. These enrichment
tools incorporate data from different public resources and
provide information about the possible involvement of the
genes of interest in biological and molecular pathways.
The COL8A1 (3q12.1) and COL6A5 (3q22.1) genes are
both located on the long arm of chromosome 3; there-
fore, we decided to evaluate the Linkage Disequilibrium
(LD) pattern in our Mediterranean samples. The LD anal-
ysis was performed on the PhAT (Pharmacogenetics of
Asthma Treatment) Website using the LD Plotter online tool
(http://pharmgat.org/Tools/pbtoldplotform). The LD Plotter
tool allows conversion of a prettybase format file into a plot
showing pairwise LD. The LD pattern has been measured in
D’which exploits allele frequencies to provide a scale of values
ranging from 0 (indicating high recombination between the
markers) to 1 (meant as low or absent recombination between
the markers). The results have been displayed in numerical
LD values and color scheme.
3. Results
A total of 428 Mediterranean patients (285 Italians, 87
Egyptians, and 56 Greeks) with a diagnosis of AE were
recruited for the study. In addition, 992 healthy individu-
als of Mediterranean ancestry and 50 Greek subjects were
utilized as control cohort. Genomic DNA was obtained
from all the patients’ samples. Successively, the samples were
genotyped for the SNPs of interest (rs12488457, rs13081855,
and rs3812111) by Real Time PCR and TaqMan chemistry.
The genotyping results were subjected to biostatistical and
bioinformatic analysis to evaluate the association with AE.
3.1. Biostatistical Results. The genotyping results related to
rs13081855 (G/T, COL8A1) were subjected to biostatisti-
cal analysis, revealing a positive association with AE in
Mediterranean cohorts [p=2.09∗10−5, OR(T) = 1.88 (CI95%:
1.40 - 2.53)], even taking into account population-specific
subgroups [Egyptian cohort: p=0.03, OR(T) = 1.77 (CI95%:
1.04 - 2.99) and Italians: p=1.32∗10−6, OR(T) = 2.20 (CI95%:
1.58 - 3.05)]. In this context, the Greek group represents
the only exception to this result, since the rs13081855 was
not associated with AE (Table 1). The allelic distribution
of rs13081855 within Greek patients is highly similar to the
frequency observed among control subjects. This result has
been further confirmed by comparing the frequencies found
in healthy individuals of Greek origin (Table 2). Given these
data, COL8A1 may be considered as a population-specific
biomarker for AE susceptibility although this association
should be replicated in other cohorts as well.
The rs12488457 (A/C, COL6A5) did not reveal any signif-
icant association among Mediterranean populations, except
for the Greek cohort. In fact, the biostatistical analysis per-
formed on the Greek group compared to the overall control
subjects reported a p=0.019 for the rs12488457 (A/C) and an
OR(C)=1.62 (CI95%:1.08-2.44) (Table 1).These resultsmay be
explained considering the allele frequencies among Mediter-
ranean patients, overall control subjects, and theGreek subset
of patients. A similar allele distribution was observed among
Mediterranean and control cohorts, in contrast to the differ-
ent frequencies reported in the Greek population (Table 1).
However, a subsequent analysis considering only patients
and controls of Greek origin resulted to be not significant
(Table 2), suggesting that COL6A5 is not a susceptibility
factor for AE in Mediterranean populations, although the
Greek cohort differs from the other Mediterranean groups as
a result of a variable allele distribution of the SNP of interest.
The biostatistical evaluation of the results obtained from
rs3812111 (A/T, COL10A1) genotyping did not report any
significant association with AE among Mediterranean pop-
ulations. As for COL6A5, only the Greek group revealed sig-
nificant values [p=0.018, OR(T) = 1.69 (CI95%: 1.09 - 2.64)],
although this result was not confirmed in the subsequent
analysis considering only Greek control individuals (Tables
1 and 2). Even in this case, the frequency distribution of
rs3812111 in Greek population differed from the frequencies
observed in the other analysed sample cohorts (Table 1).
Therefore, these results suggest that COL10A1 does not
represent a susceptibility factor for AE in Mediterranean
populations, although the Greek cohort displayed his own
peculiar allele frequency distribution compared to other
groups of Mediterranean ancestry.
3.2. Bioinformatic Results. Bioinformatic analysis was per-
formed to assess the impact of the SNPs on protein structure
and function as well as to investigate the functional role
of the analysed genes in biological processes. In particular,
the rs13081855 is an intronic variant within COL8A1 coding
for the 𝛼1 chain of Collagen VIII. Interrogation of Mutation
Taster and Human Splicing Finder did not provide evidence
of splicing alteration for this SNP. GO analysis, performed on
DAVID, reported that the gene is involved in angiogenesis
pathways.
The rs12488457 is a missense Thr/Pro polymorphism
located into the 9th exon of COL6A5 that is a gene encoding
the 𝛼5 chain of Collagen VI. Mutation Taster and ExPaSy-
ProSite outcomes reported that the SNP could potentially
affect protein structure, by altering specific domains or
protein features, namely, VWFA7 and nonhelical region,
respectively. In addition, a significant result was also pre-
dicted by Polyphen-2, which reported a score of 0.987
consistent with a strong impact of the variant, considering a
significance range between 0 (no impact) and 1 (maximum
impact). Moreover, Mutation Taster and Human Splicing
Finder indicated that the variant might also alter a regulatory
site and, consequently, influence the splicing mechanisms of
COL6A5 protein.
Gene Ontology (GO) enrichment analysis performed on
DAVID showed that COL6A5 is involved in cell adhesion
mechanisms, collagen synthesis, and catabolism. In addition,
KEGG reported the COL6A5 involvement in focal adhesion
and Pi3k/Akt pathways.
Since COL8A1 (3q12.1) and COL6A5 (3q22.1) genes are
both located on the long arm of chromosome 3, the LD
analysis was performed in order to assess the existence of
recombination between the SNPs of interest. As expected, the
LD pattern was excluded because obtained D’ values range
from 0 to 0.22 in our Mediterranean cohort.
4 BioMed Research International
Table 1: Biostatistical results obtained by analysis of Mediterranean and control subjects.
Gene (SNP) Population (N) Genotypes (Frequency) Alleles (Frequency) P OR (95%CI)
COL6A5 (rs12488457, A/C)
Mediterranean (428)
AA: 85 (0.20)
AC: 207 (0.48)
CC: 136 (0.32)
A: 377 (0.44)
C: 479 (0.56) ns -
Egyptian (87)
AA: 11 (0.13)
AC: 46 (0.53)
CC: 30 (0.34)
A: 68 (0.39)
C: 106 (0.61)
ns -
Italian (285)
AA: 68 (0.24)
AC: 137 (0.48)
CC: 80 (0.28)
A: 273 (0.48)
C: 297 (0.52)
ns -
Greek (56)
AA: 6 (0.11)
AC: 24 (0.43)
CC: 26 (0.46)
A: 36 (0.32)
C: 76 (0.68) 0.019
C: 1.62
(1.08-2.44)
Control Subjects (832)
AA: 150 (0.18)
AC: 424 (0.51)
CC: 258 (0.31)
A: 724 (0.44)
C: 940 (0.56)
COL8A1 (rs13081855, G/T)
Mediterranean (398)
GG: 314 (0.790)
GT: 81 (0.203)
TT: 3 (0.007)
G: 709 (0.89)
T: 87 (0.11) 2.09∗10
−5 T: 1.88
(1.40-2.53)
Egyptian (87)
GG: 69 (0.79)
GT: 18 (0.21)
TT: 0 (0.00)
G: 156 (0.90)
T: 18 (0.10) 0.03
T: 1.77
(1.04-2.99)
Italian (255)
GG: 194 (0.86)
GT: 58 (0.23)
TT: 3 (0.01)
G:446 (0.87)
T: 64 (0.13)
1.32∗10−6 T: 2.20
(1.58-3.05)
Greek (56)
GG: 51 (0.91)
GT: 5 (0.09)
TT: 0 (0.00)
G: 107 (0.96)
T: 5 (0.04)
ns -
Control Subjects
(883)
GG: 778 (0.881)
GT: 102 (0.116)
TT: 3 (0.003)
G: 1658 (0.94)
T: 108 (0.06)
COL10A1 (rs3812111, A/T)
Mediterranean (402)
AA: 53 (0.13)
AT: 191 (0.48)
TT: 158 (0.39)
A: 297 (0.37)
T: 507 (0.63) ns -
Egyptian (87)
AA: 10 (0.11)
AT: 47 (0.54)
TT: 30 (0.35)
A: 67 (0.39)
T: 107 (0.61) ns -
Italian (259)
AA: 41 (0.16)
AT: 121(0.47)
TT: 97 (0.37)
A: 203 (0.39)
T: 315 (0.61)
ns -
Greek (56)
AA: 2 (0.04)
AT: 23 (0.41)
TT: 31 (0.55)
A: 27 (0.24)
T: 85 (0.76)
0.018 T: 1.69
(1.09-2.64)
Control Subjects
(992)
AA: 135 (0.14)
AT: 425 (0.48)
TT: 432 (0.39)
A: 695 (0.35)
T:1289 (0.65)
Finally, the rs3812111 is an intronic variant located into
COL10A1, which is essential for the synthesis of 𝛼1 chain of
Collagen X.The interrogation ofMutation Taster andHuman
Splicing Finder did not report significant splicing changes for
this SNP compared to the wild-type sequence. On the basis
of the results collected on DAVID, COL10A1mainly exerts its
role in bone and cartilage metabolism processes as well as in
the organization and remodelling of ECM.
4. Discussion
The main purpose of the study was the investigation of
the relationship between dysregulation of ECM and the
susceptibility to AE. In particular, genes encoding collagen
proteins have been analyzed to identify candidate biomarkers
able to discriminate individuals with a higher risk of AE
with respect to the general population. Considering the high
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Table 2: Biostatistical results obtained by analysis on Greek case and control subjects.
Gene (SNP) Population (N) Genotypes (Frequency) Alleles (Frequency) P OR (95%CI)
COL6A5 (rs12488457, A/C)
Greek (56)
AA: 6 (0.11)
AC: 24 (0.43)
CC: 26 (0.46)
A: 36 (0.32)
C: 76 (0.68)
ns -
Greek Controls (50)
AA: 8 (0.16)
AC: 18 (0.36)
CC: 24 (0.48)
A: 34 (0.34)
C: 66 (0.66)
COL8A1 (rs13081855, G/T)
Greek (56)
GG: 51 (0.91)
GT: 5 (0.09)
TT: 0 (0.00)
G: 107 (0.96)
T: 5 (0.04)
ns -
Greek Controls (50)
GG: 40 (0.80)
GT: 10 (0.20)
TT: 0 (0.00)
G: 90 (0.90)
T: 10 (0.10)
COL10A1 (rs3812111, A/T)
Greek (56)
AA: 2 (0.04)
AT: 23 (0.41)
TT: 31 (0.55)
A: 27 (0.24)
T: 85 (0.76)
ns -
Greek Controls (48)
AA: 6 (0.125)
AT: 18 (0.375)
TT: 24 (0.500)
A: 30 (0.31)
T: 66 (0.69)
heterogeneity of the disease due to different susceptibility
factors in terms of geographic localization, latitude, and
frequency distribution of disease-associated genetic variants,
a cohort of 1470 subjects of Mediterranean origin has been
genotyped for three polymorphisms located on the COL6A5,
COL8A1, and COL10A1 genes.
The statistical analysis identified a positive association
of COL8A1 (rs13081855, G/T) with AE in Mediterranean
populations, except for the Greek group, as the allelic
distribution of the SNP within Greek patients is similar
to the frequency observed among control subjects. The
subsequent analysis on the three different Mediterranean
cohorts confirmed this result, suggesting that COL8A1 may
be considered as a population-specific biomarker for AE
(see Table 1). It would be interesting to replicate these data
even in other cohorts of Mediterranean ancestry. On this
subject, bioinformatic investigation performed on DAVID
highlighted the involvement of the gene in disease-associated
cellular and molecular pathways. In fact, the GO enrichment
tool of DAVID reported that COL8A1 protein contributes to
maintain the integrity and structure of vessel walls, the ECM
remodelling activity and to induce angiogenesis. On this
subject, COL8A1 has been extensively investigated in other
multifactorial disease, especially in Age-Related Macular
Degeneration (AMD). The gene has been associated with
the neovascular forms of AMD that is characterized by the
abnormal growth of blood vessels beneath the retina. In this
context, COL8A1 has been found to be associated with a
higher risk of neovascular AMD in Italian population [20,
21]. Moreover, bioinformatic analysis, performed by DAVID
and KEGG databases, revealed a significant interaction with
VEGFA that is one of the main proangiogenic factors and
it may be thereby investigated as an additional player in
the etiopathogenesis of AE. Supporting this hypothesis,
the alteration of keratinocytes metabolism is known to be
responsible for an overproduction of proangiogenic factors
which stimulate the growth of blood vessels towards the
epidermis that is normally nonvascularized. The originated
new vessels are characterized by tortuous dermal capillary
loops which may contribute to the disease exacerbation in a
similar way to that described for lesions occurring in patients
with Psoriasis (Ps) and Psoriatic Arthritis (PsA) [22]. Given
this result, it would be interesting to validate COL8A1 as a
susceptibility factor for Ps and PsA as well as studying this
gene as a candidate therapeutic target.
The genotyping analysis of COL6A5 (rs12488457, A/C)
reported similar allelic frequency distributions in our
Mediterranean cohort and control subjects, resulting thereby
in a nonsignificantly associated marker with AE. However,
the subsequent analysis performed on single populations
of Mediterranean ancestry (Italian, Egyptian and Greek)
revealed a significant association only for Greek patients
compared to general control subjects. Successively, biostatis-
tical analysis between patients and controls of Greek origin
gave nonsignificant results, suggesting that COL6A5 does not
represent a susceptibility factor for AE in Greek population
as well as in the other Mediterranean groups. Supporting
this negative result, the cellular and molecular functions of
COL6A5 protein have been evaluated by means of bioinfor-
matics approaches. COL6A5 is expressed in the dermoepi-
dermal junctions, especially within the dermal papillae where
it takes part in the metabolic activities of collagen, cellular
adhesion, and interaction of ECM proteins localized at der-
mal level. The cellular localization and function of COL6A5
may explain the lack of association with AE. In fact, the
peculiar lesions observed in AE patients normally affect the
outer layers of skin without undermining dermoepidermal
junctions. However, the association of COL6A5 with AE is
controversial in literature as some works described it as a sus-
ceptibility factor amongnon-Mediterranean populations [23]
while a case-control study including patients from Germany
and other European Countries [24, 25] did not confirm the
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previous results. The real impact of COL6A5 gene on disease
etiopathogenesis needs therefore to be clarified by further
investigations. As for COL6A5, statistical association analysis
did not report any significant association between COL10A1
(rs3812111, A/T) and AE among Mediterranean populations,
except for the Greek group, which showed to be significantly
associated with respect to general control subjects. This data
was not confirmed by comparing Greek patients and Greek
control individuals, suggesting that COL10A1 is not a suscep-
tibility factor for AE inMediterranean populations. Concern-
ing the molecular function of COL10A1 protein, bioinfor-
matic analysis revealed its implication in ECM organization,
maintenance of joints, and bone homeostasis. Therefore,
the role of COL10A1 explains the lack of association with
AE, considering that the disease is normally characterized
by the alteration of inflammatory/immune response and
epidermal differentiation mechanisms without undermining
bone tissue.
Altogether, our data indicate COL8A1 as a novel suscep-
tibility factor for AE in Mediterranean populations, except
for the Greek cohort (Table 1). Interestingly, this group of
patients showed a different frequency distribution compared
to the other analyzed cohorts ofMediterranean ancestry.This
divergence may be explained by the presence of a specific
allelic architecture within the Greek area probably due to
a positive/negative selection of genetic variants in response
to the adaptation to the local environment. Otherwise, the
different results may be due to the small sample-size available
for the study, which may have misled the real frequency
distributions within Greek population. The results obtained
in the Greek cohort have to be therefore validated on a
larger sample-size, in order to evaluate the actual relation-
ship between genetic variants in collagen genes and the
susceptibility to AE in this population. Similarly, our results
should also be replicated in other worldwide populations
characterized by different exposures to environmental factors
which may thereby interact with specific genetic features and
confer a higher/lower risk of AE.
Over the replication of our data on a larger Greek
cohort and other populations, future perspectives include
the evaluation of the association of COL6A5, COL8A1, and
COL10A1 in other skin-related disorders, such as Ps and
PsA that share similar etiopathogenetic pathways observed
in AE. In fact, the possibility of identifying differential
biomarkers for the susceptibility to AE, Ps, or PsA could be
useful for revealing novel phenotype-genotype correlations
and highlighting common and differential etiopathogenetic
pathways underlying these disorders.
5. Conclusions
The study was mainly addressed to investigate the rela-
tionship between dysregulation of ECM and the suscep-
tibility to AE. The genes of interest have been selected
considering their involvement in the organization of ECM
and immune/inflammatory responses, both of which are
known to be strongly dysregulated in AE and other complex
disorders. Particular attention was given to collagens genes,
since variations within their sequence may contribute to
generating abnormal connective tissues which are more
susceptible to mechanical stress, loss of epidermal integrity,
and aging. In the present study, three polymorphisms located
in COL6A, COL8A1, and COL10A1 were investigated as
potential susceptibility biomarkers for AE in a large cohort
of Mediterranean origin. The obtained results confirmed that
the susceptibility to AE depends on a complex interaction
between latitude/geographical localization and the differ-
ential distribution of genetic variants among populations
exposed to similar environmental factors. This relationship
can be clinically useful to stratify patients on the basis of their
individual genetic features and the exposure to environmen-
tal factors that can impact not only the onset/progression
of disease but also the response to topic treatments and,
ultimately, the quality of life of patients suffering from AE.
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